A nurse is caring for a client with systemic lupus erythematosus (SLE)who is taking hydroxychloroquine (Plaquenil). When providing care for this client, the nurse should monitor for which adverse effect associated with this medication?
A)Pulmonary fibrosis
B)Cushingoid effects
C)Retinal toxicity
D)Renal toxicity

Question

Quizplus · Accepted Answer

A)Hydroxychloroquine (Plaquenil)is an antimalarial drug that is also used to reduce the frequency of acute episodes of SLE. The primary concern with Plaquenil is retinal toxicity and possible irreversible blindness. Cushingoid effects are a concern with corticosteroid therapy. Pulmonary fibrosis is a potential adverse effect of cyclophosphamide, not Plaquenil. Renal toxicity is not the primary concern with Plaquenil.
B)Hydroxychloroquine (Plaquenil)is an antimalarial drug that is also used to reduce the frequency of acute episodes of SLE. The primary concern with Plaquenil is retinal toxicity and possible irreversible blindness. Cushingoid effects are a concern with corticosteroid therapy. Pulmonary fibrosis is a potential adverse effect of cyclophosphamide, not Plaquenil. Renal toxicity is not the primary concern with Plaquenil.
C)Hydroxychloroquine (Plaquenil)is an antimalarial drug that is also used to reduce the frequency of acute episodes of SLE. The primary concern with Plaquenil is retinal toxicity and possible irreversible blindness. Cushingoid effects are a concern with corticosteroid therapy. Pulmonary fibrosis is a potential adverse effect of cyclophosphamide, not Plaquenil. Renal toxicity is not the primary concern with Plaquenil.
D)Hydroxychloroquine (Plaquenil)is an antimalarial drug that is also used to reduce the frequency of acute episodes of SLE. The primary concern with Plaquenil is retinal toxicity and possible irreversible blindness. Cushingoid effects are a concern with corticosteroid therapy. Pulmonary fibrosis is a potential adverse effect of cyclophosphamide, not Plaquenil. Renal toxicity is not the primary concern with Plaquenil.

A Nurse Is Caring for a Client with Systemic Lupus